Fortress Biotech, Inc. Common Stock Shares Outstanding

• Fortress Biotech, Inc. showed an increase of +12.4% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Fortress Biotech, Inc.'s Common Stock Shares Outstanding has grown by 554.6%.
• Historical annual values: Fiscal year 2025: 31.36 million shares | Fiscal year 2024: 27.91 million shares | Fiscal year 2023: 15.09 million shares | Fiscal year 2022: 7.37 million shares | Fiscal year 2021: 101.44 million shares | Fiscal year 2020: 94.88 million shares | Fiscal year 2019: 74.03 million shares | Fiscal year 2018: 57.85 million shares | Fiscal year 2017: 50.99 million shares | Fiscal year 2016: 48.93 million shares | Fiscal year 2015: 47.15 million shares | Fiscal year 2014: 46.49 million shares | Fiscal year 2013: 39.65 million shares | Fiscal year 2012: 24.40 million shares | Fiscal year 2011: 18.60 million shares | Fiscal year 2010: 4.79 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026